How much does Abingworth typically invest?

Abingworth states a typical cheque of €1M – €30M.

Which stages does Abingworth invest in?

Abingworth invests at Seed, Series A and Series B.

Where is Abingworth based?

Abingworth is headquartered in London, United Kingdom.

Investor directory

Abingworth

VC fundLondon, United Kingdomabingworth.com LinkedIn

Abingworth seeks to invest in game-changing life science companies that have the potential to materially improve patients' lives.

What they invest in

Stages

Seed Series A Series B

Sectors

Biotech & Pharma HealthTech

Geographies

North AmericaEurope

The facts

Typical cheque: €1M – €30M
Headquarters: London, United Kingdom
Founded: 1973

Portfolio companies

Cytospire Therapeutics

More portfolio companies

CRISPR Therapeutics (NAS: CRSP)Phathom Pharmaceuticals (NAS: PHAT)Scorpion TherapeuticsIambicR1 TherapeuticsAllotera TherapeuticsVaxcyte (NAS: PCVX)Ceryvyn Therapeutics (ASX: CYV)Solve TherapeuticsAtsena TherapeuticsSoteria BiotherapeuticsTimberlyne TherapeuticscAMPfield TherapeuticsAntares TherapeuticsExicure (NAS: XCUR)Escient PharmaceuticalsGlycomineReneo PharmaceuticalsAdicet Bio (NAS: ACET)Effector Therapeutics (OTCM: EFTR)AdvanCellNido BiosciencesIFM TreOnKure Therapeutics (NAS: OKUR)

and 23 more

Questions founders ask

How much does Abingworth typically invest?: Abingworth states a typical cheque of €1M – €30M.
Which stages does Abingworth invest in?: Abingworth invests at Seed, Series A and Series B.
Where is Abingworth based?: Abingworth is headquartered in London, United Kingdom.

Does Abingworth fit your round?

In 30 minutes you'll know which funds matter for your round.

Request access

Search investors like this in Claude — no account, no sign-in. Open in Claude

Are you Abingworth? Tell us what to correct and we will update it — or ask us to remove the entry.